Advertisement Pharmaceutical Business review -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
September 20, 2021

Grifols to acquire Tiancheng Pharmaceutical for $1.3bn

Spanish healthcare firm Grifols has agreed to acquire 100% stake in Tiancheng (Germany) Pharmaceutical from Tiancheng International Investment for $1.289bn (€1.1bn).

Acquisition of Biotest will significantly strengthen Grifols’ industry capabilities. Credit: Gerd Altmann from Pixabay.